Concepedia

Edoardo Sarubbi

ES

Statistics

Publications

28

Citations

1.4K

H-Index

17

Active since

1988

Affiliations

Tumour Institute of Tuscany(Current)

Sanofi (France)

Affymax (United States)

National Institutes of Health

National Institute of Child Health

Edoardo Sarubbi is an author at Tumour Institute of Tuscany specializing in life sciences, molecular biology, and enzyme inhibition.

Publications per year

1988–2005

28

Publications

28

A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist

Herman Schreuder, Chantal Tardif, Susanne Trump-Kallmeyer et al. · Nature · 1997 · 245 citations

Life Sciences, Immunology, Molecular Biology +16

Basal ppGpp level adjustment shown by new spoT mutants affect steady state growth rates and rrnA ribosomal promoter regulation in Escherichia coli

Edoardo Sarubbi, Kenneth E. Rudd, Michael Cashel · Molecular and General Genetics MGG · 1988 · 169 citations

Life Sciences, Microbiology, Molecular Biology +15

Characterization of the spoT gene of Escherichia coli

Edoardo Sarubbi, Kenneth E. Rudd, Hua Xiao et al. · Journal of Biological Chemistry · 1989 · 108 citations · Full text

Life Sciences, Genetics, Microbiology +14

SAR and X-ray. A New Approach Combining Fragment-Based Screening and Rational Drug Design: Application to the Discovery of Nanomolar Inhibitors of Src SH2

Dominique Lesuisse, Gudrun Lange, Pierre Deprez et al. · Journal of Medicinal Chemistry · 2002 · 90 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Acyl Ureas as Human Liver Glycogen Phosphorylase Inhibitors for the Treatment of Type 2 Diabetes

Thomas Klabunde, K. Ulrich Wendt, Dieter Kadereit et al. · Journal of Medicinal Chemistry · 2005 · 73 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

1–5 of 28